Alto Neuroscience
Clinical trials sponsored by Alto Neuroscience, explained in plain language.
-
New depression drug shows early promise in mood and alertness
Disease control CompletedThis study tested an experimental drug called ALTO-203 in people with moderate depression and loss of pleasure (anhedonia). Researchers gave 69 participants either the drug or a placebo to see how it affected their mood and alertness, and to check if it was safe. The goal was to …
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Personalized depression drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether ALTO-100, a new investigational medication, helps reduce symptoms of major depression. It involved 301 adults with moderate to severe depression, who took the drug either by itself or added to their current antidepressant for 6 weeks. Researchers measure…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC